Glück, Stefan <br/><br/>
XeNA: capecitabine plus docetaxel, with or without trastuzumab, as preoperative therapy for early breast cancer.  [electronic resource] 

 -  International journal of medical sciences  2008 
 - 341-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1449-1907 
<br/><br/><label>Standard No.: </label>10.7150/ijms.5.341  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Breast Neoplasms--drug therapy<br/>Capecitabine<br/>Deoxycytidine--analogs & derivatives<br/>Docetaxel<br/>Female<br/>Fluorouracil--analogs & derivatives<br/>Humans<br/>Immunotherapy<br/>Middle Aged<br/>Neoadjuvant Therapy<br/>Preoperative Care<br/>Taxoids--therapeutic use<br/>Trastuzumab<br/>Treatment Outcome